DSM Integrated Annual Report 2021

Key business figures at a glance

Our activities are grouped in three clusters: Nutrition, Materials and Innovation Center. We report separately on Corporate Activities. Results presented in this section (and elsewhere in this Report) relate to consolidated activities only (therefore non-consolidated partnerships are excluded).

Net sales

x € million

 

2021

 

2020

 

 

 

 

 

Nutrition

 

7,031

 

6,365

Materials

 

1,935

 

1,518

Innovation Center

 

168

 

184

Corporate Activities

 

70

 

39

Total continuing operations

 

9,204

 

8,106

 

 

 

 

 

Discontinued operations

 

264

 

932

Total

 

9,468

 

9,038

Adjusted operating profit (EBIT)

x € million

 

2021

 

2020

 

 

 

 

 

Nutrition

 

940

 

919

Materials

 

331

 

168

Innovation Center

 

4

 

(17)

Corporate Activities

 

(136)

 

(141)

Total continuing operations

 

1,139

 

929

 

 

 

 

 

Discontinued operations

 

28

 

82

Total

 

1,167

 

1,011

Adjusted EBITDA

x € million

 

2021

 

2020

 

 

 

 

 

Nutrition

 

1,447

 

1,338

Materials

 

435

 

272

Innovation Center

 

26

 

21

Corporate Activities

 

(94)

 

(97)

Total continuing operations

 

1,814

 

1,534

 

 

 

 

 

Discontinued operations

 

28

 

116

Total

 

1,842

 

1,650

Capital employed at 31 December

x € million

 

2021

 

2020

 

 

 

 

 

Nutrition

 

9,550

 

8,305

Materials

 

1,005

 

953

Innovation Center

 

407

 

436

Corporate Activities

 

(1)

 

-

Total continuing operations

 

10,961

 

9,694

 

 

 

 

 

Discontinued operations

 

51

 

863

Total

 

11,012

 

10,557

Adjusted EBITDA margin

in %

 

2021

 

2020

 

 

 

 

 

Nutrition

 

20.6

 

21.0

Materials

 

22.5

 

17.9

Total continuing operations

 

19.7

 

18.9

 

 

 

 

 

Discontinued operations

 

10.6

 

12.4

Total

 

19.5

 

18.3

ROCE

in %

 

2021

 

2020

 

 

 

 

 

Nutrition

 

10.6

 

12.6

Materials

 

34.1

 

16.4

Total continuing operations

 

11.1

 

10.4

 

 

 

 

 

Discontinued operations

 

-

 

9.2

Total

 

11.1

 

10.3

Capital expenditure

x € million

 

2021

 

2020

 

 

 

 

 

Nutrition

 

488

 

441

Materials

 

65

 

63

Innovation Center

 

2

 

35

Corporate Activities

 

53

 

34

Total continuing operations

 

608

 

573

 

 

 

 

 

Discontinued operations

 

6

 

49

Total, accounting based

 

614

 

622

 

 

 

 

 

Non-cash items

 

(44)

 

(13)

Customer funding

 

-

 

(24)

Total, cash-based

 

570

 

585

 

 

 

 

 

In % of net sales

 

6.0

 

6.5

Workforce at 31 December

headcount

 

2021

 

2020

 

 

 

 

 

Nutrition

 

16,091

 

15,838

Materials

 

2,885

 

2,857

Innovation Center

 

578

 

579

Corporate Activities

 

1,804

 

2,039

Total continuing operations

 

21,358

 

21,313

 

 

 

 

 

Discontinued operations

 

-

 

1,814

Total

 

21,358

 

23,127

R&D expenditure (including associated IP expenditure)

 

 

x € million

 

as % of net sales

 

 

2021

 

2020

 

2021

 

2020

 

 

 

 

 

 

 

 

 

Nutrition

 

257

 

241

 

3.7

 

3.8

Materials

 

79

 

73

 

4.1

 

4.8

Innovation Center

 

45

 

60

 

24.5

 

32.6

Corporate Activities

 

21

 

11

 

30.0

 

28.2

Total continuing operations

 

402

 

385

 

4.4

 

4.7

 

 

 

 

 

 

 

 

 

Discontinued operations

 

13

 

60

 

4.9

 

6.4

Total

 

415

 

445

 

4.4

 

4.9